ArticleFrontiers in oncology2018

Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.

Cristian Scatena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.